| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $203,383,869 ) (Continued on the next page) |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM157099 | Defining a biophysical basis for cell types, cell states and cellular heterogeneity at single-cell resolution | 000 | 2 | NIH | 1/16/2026 | $343,062 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM156916 | Gene regulatory networks for hair cell regeneration | 001 | 2 | NIH | 3/19/2026 | $38,802 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM156916 | Gene regulatory networks for hair cell regeneration | 000 | 2 | NIH | 12/15/2025 | $349,219 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM162386 | Mechanobiological regulations of collective cell movement: insights from in vivo to in vitro | 000 | 1 | NIH | 3/19/2026 | $412,124 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM161776 | Probe translation regulation by imaging single protein-mRNA interaction in live cells | 000 | 1 | NIH | 2/18/2026 | $426,250 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM161901 | Mechanisms of Protein Self-Assembly Coupled to Membrane Mechanics in the Cell | 000 | 1 | NIH | 3/13/2026 | $420,936 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM162486 | CHARACTERIZING FLAGELLAR MOTILITY IN THE CONTEXT OF HOST-MICROBE SYMBIOSIS | 000 | 1 | NIH | 3/16/2026 | $388,333 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM124883 | The influence of neuronal states on perception and behavior | 001 | 9 | NIH | 3/27/2026 | $42,950 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM124883 | The influence of neuronal states on perception and behavior | 000 | 9 | NIH | 12/16/2025 | $386,553 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R34MH133617 | The Caregiver-Informed Treatment Engagement (CITE) Program: a Pilot Trial of a Youth Mental Health Treatment Engagement Intervention | 000 | 2 | NIH | 4/8/2026 | $236,458 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | T32AI007291 | Research Training in Microbial Diseases | 000 | 36 | NIH | 4/13/2026 | $439,712 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | T32AI102623 | Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program | 000 | 14 | NIH | 4/8/2026 | $408,845 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AI157931 | A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV) | 000 | 5 | NIH | 3/19/2026 | $976,602 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AG032947 | The National Health and Aging Trends Study and National Study of Caregiving | 001 | 18 | NIH | 3/10/2026 | $16,950,861 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AI165826 | Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75 | 000 | 5 | NIH | 12/2/2025 | $1,574,291 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R50CA275932 | Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist | 000 | 4 | NIH | 3/19/2026 | $105,619 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R61AI179998 | Generation and characterization of a large-scale transposon mutant library of Rickettsia parkeri | 000 | 3 | NIH | 1/6/2026 | $274,592 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AI168287 | Solving Opportunities for Spillover (SOS): Frequency and Mechanisms of Cross-species Transmission of Henipaviruses in Bangladesh | 000 | 4 | NIH | 1/23/2026 | $628,892 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AI182032 | Clinical Research Unit: Johns Hopkins University | 000 | 3 | NIH | 2/5/2026 | $390,000 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01DC019364 | Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction | 000 | 6 | NIH | 4/1/2026 | $580,697 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01DA060708 | Phase III double-blind, randomized controlled trial of suvorexant versus placebo to treat insomnia in persons with opioid use disorder | 000 | 3 | NIH | 3/5/2026 | $5,833,132 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01HD107957 | Delineation of the natural history of Ollier disease and Muffucci syndrome and investigation of their genetic bases | 001 | 4 | NIH | 3/26/2026 | $53,831 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01HD107957 | Delineation of the natural history of Ollier disease and Muffucci syndrome and investigation of their genetic bases | 000 | 4 | NIH | 1/28/2026 | $484,471 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01DK134975 | The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetes | 000 | 4 | NIH | 4/9/2026 | $398,268 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UG1EY033286 | NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa | 000 | 5 | NIH | 4/9/2026 | $344,858 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UG3AG090673 | Building Research Infrastructure for Alzheimer's Disease and Related Dementias in Cote d'Ivoire | 000 | 2 | NIH | 4/6/2026 | $166,376 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UH3HL151458 | 1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension | 000 | 5 | NIH | 2/26/2026 | $491,662 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UH3AR079376 | Injection of autologous volar fibroblasts to the stump site to allow pressure adaptation and enhanced prosthetic use in amputees | 001 | 5 | NIH | 3/4/2026 | $511,643 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069518 | The Johns Hopkins University-Blantyre Clinical Trials Unit | 002 | 20 | NIH | 2/18/2026 | -$455,628 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069518 | The Johns Hopkins University-Blantyre Clinical Trials Unit | 001 | 20 | NIH | 12/20/2025 | $455,628 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069465 | Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | 000 | 20 | NIH | 1/22/2026 | $1,261,833 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069518 | The Johns Hopkins University-Blantyre Clinical Trials Unit | 000 | 20 | NIH | 12/9/2025 | $380,038 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 009 | 20 | NIH | 1/1/2026 | $82,108 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 008 | 20 | NIH | 12/31/2025 | $3,000 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 007 | 20 | NIH | 12/30/2025 | $23,121 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 006 | 20 | NIH | 12/29/2025 | $1 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069530 | The Johns Hopkins University - Uganda Clinical Trials Unit | 003 | 20 | NIH | 1/16/2026 | $591,521 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 005 | 20 | NIH | 12/28/2025 | $1 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069530 | The Johns Hopkins University - Uganda Clinical Trials Unit | 002 | 20 | NIH | 1/15/2026 | $205,938 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 004 | 20 | NIH | 12/27/2025 | $1 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069530 | The Johns Hopkins University - Uganda Clinical Trials Unit | 001 | 20 | NIH | 1/14/2026 | $279,483 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 003 | 20 | NIH | 12/26/2025 | $8,784 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 002 | 20 | NIH | 12/25/2025 | $15,601 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 001 | 20 | NIH | 12/24/2025 | $15,043 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069518 | The Johns Hopkins University-Blantyre Clinical Trials Unit | 005 | 20 | NIH | 4/2/2026 | $540,239 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 000 | 20 | NIH | 12/20/2025 | $6,002,340 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI069518 | The Johns Hopkins University-Blantyre Clinical Trials Unit | 004 | 20 | NIH | 4/1/2026 | $380,036 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068632 | IMPAACT Leadership Group | 000 | 20 | NIH | 12/20/2025 | $750,000 |
| | 2026 | 2026 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 20 | NIH | 1/21/2026 | $4,488,499 |
|
